Status:

COMPLETED

The Efficacy of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction

Lead Sponsor:

Glostrup University Hospital, Copenhagen

Conditions:

Anterior Cruciate Ligament Reconstruction

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

The Purpose of this study is to determine whether Adductor-Canal-Block is superior to placebo when it comes to analgetic efficacy after reconstruction of the anterior cruciate ligament.

Eligibility Criteria

Inclusion

  • 18-70 years
  • Reconstruction of Anterior Cruciate Ligament
  • Written consent
  • ASA I-II
  • BMI 19-35

Exclusion

  • Unable to communicate in Danish
  • Allergic reactions toward drugs used in the trial
  • Pregnancy
  • Abuse of alcohol/drugs
  • Daily opioid intake
  • Infection at injection site
  • Can not be mobilised to 5 meters of walk; pre-surgery

Key Trial Info

Start Date :

May 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2012

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01212666

Start Date

May 1 2010

End Date

March 1 2012

Last Update

September 11 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Anaesthesiology, Glostrup University Hospital

Copenhagen, Glostrup, Denmark, 2600

The Efficacy of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction | DecenTrialz